From 14 months to pre-Fontan , the treatment groups were similar with respect to decline in indexed neo-aortic valve area , > mild neo-aortic valve regurgitation ( < 5 % at each time ) , indexed tricuspid valve area , andmoderate tricuspid valve regurgitation ( < 20 % at each time ) .